In addition to the MGMT methylation status, we compared clinical parameters of our long-term GBM patients like age, Karnofsky-performance score, ratio male/female, localisation of the primary tumour, extent of surgery, laterality of the primary tumour, incidence of cognitive impairment and of ischemic events, incidence of relapses, median survival, to those of other reports of long-term survivors with GBM. Here, MGMT is linked to Cognitive impairment.